Glaucoma Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Prostaglandin Analogs, Beta-blockers, Adrenergic Agonists, Carbonic Anhydrase Inhibitors); By Distribution Channel; By Disease Type; By Region; Segment Forecast, 2022 - 2030
The global glaucoma market size is expected to reach USD 9.77 billion by 2030, according to a new study by Polaris Market Research. The report “Glaucoma Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Prostaglandin analogs, Beta-blockers, Adrenergic agonists, Carbonic anhydrase inhibitors, and Others); By Distribution Channel; By Disease Type; By Region; Segment Forecast, 2022 – 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising prevalence of glaucoma across the globe is the key factor bolstering market growth over the forecast period. Glaucoma is gradually becoming more common among the senior population. The elderly population’s increased use of technology, such as smartphones and laptops, is contributing to the rise in glaucoma cases. As per the International Agency for the Prevention of Blindness, in the entire world, glaucoma is the third most common cause of blindness and the fourth most prevalent cause of visual loss.
According to estimates, at least 3 million people are currently blind, and 4 million have glaucoma-related mild to severe vision problems. At least 50 percent of glaucoma sufferers are not aware of their condition. 90% of glaucoma cases in some developing nations go undiagnosed.
Further, it also estimated that, in 2018, glaucoma affected 1.9% of Americans over 40 age. According to estimates, there will be 112 million cases of glaucoma by 2040, up from 76 million in 2020. Vision impairment has become a prominent public health issue as the world’s population ages.
One billion people worldwide in 2020 have presbyopia or impaired distance vision. This number is projected to rise to 1/8 billion by 2050. In later life (>60 years), common causes of visual impairment, such as cataracts, glaucoma, age-related vision problems, diabetes mellitus, and presbyopia, are increasingly common.
The market for glaucoma is expanding at a remarkable rate, primarily because of the rising elderly population. The risk of glaucoma is most significant in the elderly population, yet it can also afflict people of other ages. People with diabetes and a history of glaucoma in their families are two more high-risk populations. Other market-driving drivers include rising awareness, rising healthcare costs, and screening.
Glaucoma Market Report Highlights
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook